Gerresheimer - GRRMY STOCK NEWS

Welcome to our dedicated page for Gerresheimer news (Ticker: GRRMY), a resource for investors and traders seeking the latest updates and insights on Gerresheimer stock.

Gerresheimer is an innovative provider of systems and solutions for the pharma, biotech, and cosmetic industries, offering a wide range of pharmaceutical containment solutions, drug delivery systems, medical devices, and digital solutions for therapy support. With a global presence and over 11,000 employees, the company generated revenues of approximately €1.82bn in 2022.

10/18/2023 07:47 AM

News

Gerresheimer awarded EcoVadis Gold status again

Rhea-AI Summary

Gerresheimer awarded Gold status by EcoVadis for its CSR performance

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Gerresheimer with positive start to the financial year 2021

Rhea-AI Summary

Gerresheimer AG reported a strong start to 2021, achieving revenues of EUR 303 million in Q1, a 3.1% increase year-on-year. Growth was driven by the Plastics & Devices Division, with a notable demand for syringes and pharmaceutical packaging. Adjusted EBITDA rose to EUR 54 million, reflecting a 29.3% year-on-year increase in adjusted earnings per share at EUR 0.57. The company forecasts mid single-digit revenue growth for 2021 and aims for an adjusted EBITDA margin of 22-23%. Gerresheimer is expanding production for Covid-19 vaccine vials, reinforcing its role in the pandemic response.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

FAQ

What is the market cap of Gerresheimer (GRRMY)?

The market cap of Gerresheimer (GRRMY) is approximately 3.9B.

What does Gerresheimer do?

Gerresheimer is a provider of systems and solutions for the pharma, biotech, and cosmetic industries, offering pharmaceutical containment solutions, drug delivery systems, medical devices, and digital solutions for therapy support.

How many employees does Gerresheimer have?

Gerresheimer has over 11,000 employees globally.

Where is Gerresheimer headquartered?

Gerresheimer is headquartered in Duesseldorf, Germany.

What is Gerresheimer's revenue in 2022?

Gerresheimer generated revenues of around €1.82bn in 2022.

In which stock exchange is Gerresheimer listed?

Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).

What is the status of Gerresheimer's sustainability performance?

Gerresheimer has been awarded Gold status by EcoVadis, demonstrating consistent implementation of its CSR strategy.

How many production sites does Gerresheimer have?

Gerresheimer has 36 production sites in 16 countries across Europe, America, and Asia.

What products does Gerresheimer offer?

Gerresheimer offers a comprehensive portfolio of pharmaceutical containment solutions, drug delivery systems, medical devices, and digital solutions for therapy support.

What are Gerresheimer's sustainability targets?

Gerresheimer has set ambitious sustainability goals that it systematically pursues and is measured by its performance.

What external sustainability ratings does Gerresheimer have?

Gerresheimer's sustainability performance is evaluated by MSCI, Sustainalytics, ISS, and other agencies, with the company publishing a sustainability report annually.

What is the purpose of Gerresheimer's sustainability initiatives?

Gerresheimer aims to provide transparent, sound, and comparable information on its sustainability activities, targets, and outcomes in accordance with best practice standards.